BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 3113406)

  • 1. Massive hollow fiber clotting: a distinct problem in treatment of cryoglobulinemia by membrane plasmapheresis.
    Lai KN; Cheng SC; Vallance-Owen J
    Artif Organs; 1987 Jun; 11(3):259-64. PubMed ID: 3113406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic apheresis: when things go wrong.
    Torloni AS; Lumadue J; Zubair A
    J Clin Apher; 2012; 27(3):168-71. PubMed ID: 22504899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of emergency apheresis in the management of plasma cell disorders.
    Kalayoglu-Besisik S
    Transfus Apher Sci; 2018 Feb; 57(1):35-39. PubMed ID: 29477943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmapheresis and paraproteinemia: cryoprotein-induced diseases, monoclonal gammopathy, Waldenström's macroglobulinemia, hyperviscosity syndrome, multiple myeloma, light chain disease, and amyloidosis.
    Siami GA; Siami FS
    Ther Apher; 1999 Feb; 3(1):8-19. PubMed ID: 10079800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmapheresis and cold sensitivity of immunoglobulin molecules. I. A study of hyperviscosity, cryoglobulinemia, euglobulinemia and macroglobulinemia vera.
    Waldenström JG; Raiend U
    Acta Med Scand; 1984; 216(5):449-66. PubMed ID: 6441457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical relevance of fractionation characteristics in cascade filtration.
    Busnach G; Mandelli E; Brando B; Brunati C
    Int J Artif Organs; 1993 Dec; 16 Suppl 5():155-9. PubMed ID: 8013978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effectiveness of plasmapheresis on the PF-0.5 blood separator in patients with paraproteinemic hemoblastoses].
    Abdullaev OM; Postnikov AA; Prigozhina TA; Likhovetskaia ZM; Mokeeva RA
    Ter Arkh; 1987; 59(10):77-81. PubMed ID: 2448887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Waldenström's macroglobulinemia: hyperviscosity syndrome and cryoglobulinemia.
    Stone MJ
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):97-9. PubMed ID: 19362986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HDL-cholesterol sparing and APO-B removal in recycled cascade plasmafiltration.
    Busnach G; Brando B; Dal Col A; Perrino ML; Zoppi F; Minetti L
    ASAIO Trans; 1986; 32(1):168-70. PubMed ID: 3096353
    [No Abstract]   [Full Text] [Related]  

  • 10. [Alleviation of ocular complications of the hyperviscosity syndrome in Waldenström's macroglobulinemia using plasma exchange].
    Malecaze F; Mathis A; Gonzales C; Lloveras JJ; Goudable C; Arlet P; Bec P
    J Fr Ophtalmol; 1986; 9(5):367-71. PubMed ID: 3100607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperviscosity syndrome: efficacy and comparison of plasma exchange by plasma separation and cascade filtration in patients with immunocytoma of Waldenström's type.
    Höffkes HG; Heemann UW; Teschendorf C; Uppenkamp M; Philipp T
    Clin Nephrol; 1995 May; 43(5):335-8. PubMed ID: 7634550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence-based focused review of management of hyperviscosity syndrome.
    Stone MJ; Bogen SA
    Blood; 2012 Mar; 119(10):2205-8. PubMed ID: 22147890
    [No Abstract]   [Full Text] [Related]  

  • 13. Biochemical and clinical evaluation of a new cellulose diacetate secondary filter for cascade filtration.
    Valbonesi M; Tarantino M; Montani F; Florio G; Romorini A
    Int J Artif Organs; 1985 Mar; 8(2):105-8. PubMed ID: 3921467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma exchange in the long-term management of Waldenström's macroglobulinemia.
    Buskard NA; Galton DA; Goldman JM; Kohner EM; Grindle CF; Newman DL; Twinn KW; Lowenthal RM
    Can Med Assoc J; 1977 Jul; 117(2):135-7. PubMed ID: 406031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of plasmapheresis in Waldenström's macroglobulinemia.
    Stone MJ; Bogen SA
    Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):238-40. PubMed ID: 23522642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of intensive plasmapheresis on the "syndrome of increased viscosity" and blood coagulation system in Waldenstrom's macroglobulinemia].
    Mokeeva RA; Zhuravlev VS
    Probl Gematol Pereliv Krovi; 1969 Mar; 14(3):8-16. PubMed ID: 4981700
    [No Abstract]   [Full Text] [Related]  

  • 17. Hyperviscosity syndrome in Waldenström's macroglobulinemia.
    Krol TC; Wood WS
    Am Fam Physician; 1981 Aug; 24(2):187-9. PubMed ID: 6789661
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful use of cryocrit for monitoring response to therapeutic plasma exchange in type 1 cryoglobulinemia.
    Olson N; Yerrabothala S; Dunbar N
    J Clin Apher; 2016 Aug; 31(4):403-4. PubMed ID: 26194475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and rheological studies in a patient with hyperviscosity syndrome due to Waldenström's macroglobulinemia.
    Somer T; Ditzel J
    Bibl Haematol; 1981; (47):242-6. PubMed ID: 6802129
    [No Abstract]   [Full Text] [Related]  

  • 20. [Selective depuration of plasma by filtration. An alternative to plasma exchange].
    Puig LL; Mazzara R; Montesinos A; Gelabert A; Castillo R
    Sangre (Barc); 1988 Apr; 33(2):114-20. PubMed ID: 3135612
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.